Ionis Pharmaceuticals Inc
SWB:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
SWB:ISI
|
US |
|
F
|
Fast Retailing Co Ltd
F:FR7
|
JP |
|
W
|
Westport Fuel Systems Inc
NASDAQ:WPRT
|
CA |
|
CVR Energy Inc
F:FL9
|
US |
|
K
|
Korea Electric Power Corp
SWB:KOP
|
KR |
|
FibroGen Inc
F:1FG0
|
US |
|
A
|
Airbus SE
XHAM:AIR
|
NL |
|
R
|
Raymond James Financial Inc
F:RJF
|
US |
|
Aegean Airlines SA
OTC:AGZNF
|
GR |
|
P
|
Petroleo Brasileiro SA Petrobras
DUS:PJXC
|
BR |
|
C
|
Charles Schwab Corp
F:SWG
|
US |
|
Banca Mediolanum SpA
LSE:0RDO
|
IT |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
F
|
Fastenal Co
XHAM:FAS
|
US |
|
N
|
NRJ Group SA
XBER:NR8
|
FR |
|
N
|
Niterra Co Ltd
XMUN:NGK
|
JP |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 92.27 EUR with a low forecast of 41.03 EUR and a high forecast of 120.55 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
92.27
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 92.27 EUR with a low forecast of 41.03 EUR and a high forecast of 120.55 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
